A Review on Analytical Method Development and Stability Indicating HPTLC Method for Alpha lipoic Acid

Alpha lipoic acid (ALA), also known as thioctic acid, is a sulfur-containing fatty acid that acts as a potent antioxidant and an essential cofactor in mitochondrial oxidative metabolism. It is widely used in pharmaceutical formulations for diabetic neuropathy and oxidative stress-related diseases. However, ALA is chemically unstable and readily undergoes degradation when exposed to acidic, alkaline, oxidative, thermal, and photolytic conditions. Therefore, stability-indicating analytical methods are required to accurately determine the active pharmaceutical ingredient (API) in the presence of degradation products. Among chromatographic techniques, HPTLC offers advantages such as low solvent consumption, simultaneous analysis of multiple samples, shorter analysis time, and lower operating cost. 

2. Drug Profile of Alpha Lipoic Acid

Chemical name:    Alpha lipoic Acid.            

Molecular formula:  C8H14O2S2.                  

Molecular weight:    206.33g/mol.                    

Category:  Antioxidant.                                            

Dosage form:  Tablet, Capsule

3. Principle of HPTLC.                                      

HPTLC is an advanced form of thin-layer chromatography using precoated silica gel plates with finer particle size and densitometric detection. It provides improved resolution, accuracy, reproducibility, and sensitivity. HPTLC is particularly useful for routine quality control because several samples can be analyzed simultaneously with minimal solvent consumption. 

4. Method Development for Alpha Lipoic Acid

The important steps include:

• Selection of silica gel 60 F254 HPTLC plates.
• Optimization of the mobile phase.
• Sample preparation and application.
• Chamber saturation.
• Plate development.
• Derivatization (if required).
• Densitometric scanning.
• Optimization of Rf value and peak resolution.                                              
• A published stability-indicating HPTLC method used toluene: chloroform: methanol: formic acid (5:3:1:0.05, v/v/v/v) as the mobile phase, achieving an Rf of approximately 0.28 ± 0.05 for ALA and good linearity over 80–400 ng/spot.                                                                                                                                                                       

5. Forced Degradation Studies

Stress testing should include:

• Acid degradation
• Alkali degradation
• Oxidative degradation
• Thermal degradation
• Photolytic degradation
• Neutral hydrolysis

The reported HPTLC method resolved 13 degradation products, demonstrating excellent specificity and stability-indicating capability. 

6. Validation Parameters (ICH Guidelines)

The developed HPTLC method should be validated for

• Specificity
• Linearity
• Accuracy
• Precision
• Repeatability
• Intermediate precision
• Robustness
• Ruggedness
• Limit of Detection (LOD)
• Limit of Quantification (LOQ)
• System suitability

These parameters ensure that the method is reliable for routine pharmaceutical quality control. 

7. Advantages of Stability-Indicating HPTLC

• Simple and economical.
• Simultaneous analysis of multiple samples.
• Low solvent consumption.
• Short analysis time.
• Good sensitivity and precision.
• Effective separation of degradation products.
• Suitable for routine quality control and stability studies. 

CONCLUSION

Stability-indicating HPTLC methods provide an efficient, accurate, and cost-effective approach for the determination of alpha lipoic acid in bulk drug and pharmaceutical dosage forms. Published methods have demonstrated successful separation of ALA from degradation products under various stress conditions and have been validated according to ICH guidelines. These methods are well suited for routine quality control, stability studies, and regulatory applications.

REFERENCES

1. Ahuja, S., & Rasmussen, H. (2011). HPLC method development for pharmaceuticals. Elsevier.
2. Aubry, A.-F., Tattersall, P., & Ruan, J. (2009). Development of stability indicating methods. Handbook of Stability Testing in Pharmaceutical Development: Regulations, Methodologies, and Best Practices, 139–161.
3. Awuchi, C. G., Twinomuhwezi, H., & Awuchi, C. G. (2022). Hyphenated techniques. In Analytical Techniques in Biosciences (pp. 125–145). Elsevier.
4. Bahatkar, G., Kurmi, M. S., Jadhao, M., & Waghulkar, V. M. (2021). Solvent effect on the UV absorption spectra of evogliptin tartrate. European Journal of Biomedical, 8(9), 395–397.
5. Bakshi, M., & Singh, S. (2002). Development of validated stability-indicating assay methods—Critical review. Journal of Pharmaceutical and Biomedical Analysis, 28(6), 1011–1040.
6. Bari, A. K., Prajapati, P. R., Modi, V. S., & Desai, S. S. (2015). Development and validation of UV spectrometric method for quantitative determination of ulipristal acetate. International Journal of Pharmacy and Pharmaceutical Sciences, 7(7).
7. Baviskar, K. P., Jain, D. V., Pingale, S. D., Wagh, S. S., Gangurde, S. P., Shardul, S. A., Dahale, A. R., & Jain, K. S. (2022). A Review on Hyphenated Techniques in Analytical Chemistry. Current Analytical Chemistry, 18(9), 956–976.
8. Béni, Z., Orgoványi, J., Kóti, J., Sánta, C., Horváth, J., Mahó, S., & Szántay Jr, C. (2014). Detection by HPLC and structural characterization by NMR and MS of a natural deuterium isotopologue of ulipristal acetate. Journal of Pharmaceutical and Biomedical Analysis, 98, 279–286.
9. Blessy, M., Patel, R. D., Prajapati, P. N., & Agrawal, Y. (2014). Development of forced degradation and stability indicating studies of drugs—A review. Journal of Pharmaceutical Analysis, 4(3), 159–165.
10. Borowczyk, K., Olejarz, P., Chwatko, G., Szylberg, M., & G\lowacki, R. (2020). A simplified method for simultaneous determination of α-lipoic acid and lowmolecular mass thiols in human plasma. International Journal of Molecular Sciences, 21(3), 1049.
11. Chandak, D., & Sharma, P. (2020). Development and validation for simultaneous estimation of gabapentin, mecobalamin and alpha lipoic acid in tablet formulation. Research Journal of Science and Technology, 12(1), 74–78.
12. Dong, M. W. (2019). HPLC and UHPLC for Practicing Scientists. John Wiley & Sons. Farid, J. F., Mostafa, N. M., Fayez, Y. M., Essam, H. M., & ElTanany, B. M. (2022).
13. Chemometric quality assessment of Paracetamol and Phenylephrine Hydrochloride with Paracetamol impurities; comparative UV-spectrophotometric implementation of four predictive models. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 265, 120308.
14. Gong, A., & Zhu, X. (2015). Dispersive solvent-free ultrasound-assisted ionic liquid dispersive liquid–liquid microextraction coupled with HPLC for determination of ulipristal acetate. Talanta, 131, 603–608.
15. González, A. G., & Herrador, M. Á. (2007). A practical guide to analytical method validation, including measurement uncertainty and accuracy profiles. TrAC Trends in Analytical Chemistry, 26(3), 227–238.
16. Gorumutchu, G. P., & Ratnakaram, V. N. (2019). Extractive spectrophotometric determination of ulipristal acetate using naphthol blue black. Research Journal of Pharmacy and Technology, 12(3), 1347–1352.
17. Guideline, I. H. T. (2006). Impurities in new drug substances Q3A (R2). Proceedings of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva, Switzerland, 25. Hanai, T. T. (1999). HPLC.
18. ICH, I. & others. (2005). Q2 (R1): Validation of analytical procedures: Text and methodology. International Conference on Harmonization, Geneva, 1–13.
19. Iram, F., Iram, H., Iqbal, A., & Husain, A. (2016). Forced degradation studies. Journal of Analytical & Pharmaceutical Research, 3(6), 73.
20. Jeffery, G. (2022). Vogel’s Textbook of Quantitative Chemical Analysis 5th Ed. A John Wiley & Sons, INC.
21. Kamdar, G., & Desai, S. (2020). Optimization and validation of HPTLC method for estimation of ulipristal acetate in presence of its forced degradation products. Journal of Chromatographic Science, 58(5), 427–432.).